tiprankstipranks
Shield Therapeutics PLC (GB:STX)
LSE:STX
Holding GB:STX?
Track your performance easily

Shield Therapeutics (STX) Cash flow

17 Followers

Shield Therapeutics Cash Flow

GB:STX's free cash flow for Q4 2021 was £―. For the 2021 fiscal year, GB:STX's free cash flow was decreased by £-14.36M and operating cash flow was £―. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
-£ -37.13M£ -23.43M£ -16.74M£ -1.40M£ -4.07M
Investing Cash Flow
-£ -2.43M£ -2.25M£ -2.05M£ -20.00K£ -1.37M
Financing Cash Flow
-£ 49.66M£ 8.53M£ 27.58M£ -47.00K£ -203.00K
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
-£ 13.37M£ -6.17M£ 12.12M£ 2.94M£ 4.14M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
-£ 26.38M-£ 27.70M£ 6.00K£ 26.00K
Issuance Of Debt
-£ 28.90M£ 8.83M---
Repayment Of Debt
-£ 18.90M£ -252.00K---
Free Cash Flow
-£ -40.07M£ -25.72M£ -16.74M£ -1.40M£ -4.07M
Domestic Sales
------
Foreign Sales
------
Currency in GBP

Shield Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis